Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
This medication is available in various forms, with the troche form being a unique one
Main pathway: VEGFR2 and angiogenesis The best-characterized pharmacological cascade of BPC-157 involves the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) receptor
Wilding, D.M., et al
Researchers also study TB-500 , a synthetic peptide based on the active region of the naturally occurring actin-binding protein thymosin beta-4
This effect can increase sympathetic outflow and potentiate the release of norepinephrine from nerve endings, leading to activation of 1 and 1 receptors in the heart and peripheral vasculature, with a consequent rise in blood pressure Blocks presynaptic 2 adrenergic receptors Indications: Rarely used Sometimes used in the treatment of orthostatic hypotension because it promotes norepinephrine release through blockade of 2 receptors in both the central nervous system and the periphery There is some evidence that it may be possibly effective in treating erectile dysfunction & SSRI related sexual dysfunction in both men & women by unclear mechanisms (NIH Medlineplus) Has been suggested to have aphrodisiac properties Side Effects: Yohimbine exerts a stimulating action on the mood and may increase anxiety Major drug Interactions: Yohimbine can reverse the antihypertensive effects of an 2 receptor agonist such as clonidine, a potentially serious adverse drug interaction References: Biaggioni I (2021): Adrenoceptor Antagonists (Chapter 10)
EC 1.11.1.9) belongs to the peroxidase family and is commonly used in biochemical research
US$ 25.76
US$ 27.81
US$ 22.92
US$ 26.91
